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Artificial intelligence is disrupting the world of medical imaging. 
Algorithms and models, already very present in the construction of 
medical images, are now powerful enough to guide the analysis of 
medical images as well as, if not better, human experts. These 
algorithms allow the construction of digital representations of the 
patient that guide diagnosis, prognosis and therapeutic management. 
On May 2, 2018, a symposium at the Collège de France brought 
together many experts on this subject. Their contributions are visible 
on the Collège 1 website. 
In dermatology, a deep convolutional network, previously trained 
on more than one-million natural images, was then adjusted with the 
images of 130,000 dermatological lesions, to learn to automatically 
distinguish cancerous lesions from benign ones as well as an expert 
dermatologist. In radiology, the French company Therapixel has 
developed a deep convolutional network with  
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640,000 mammograms from a global challenge, and won the 
competition by distinguishing suspicious mammograms from normal 
ones better than all its competitors. Its software now surpasses the 
performance of expert radiologists. Finally, in ophthalmology, other 
deep convolutional networks, trained on more than 130,000 images of 
the retina, are able to detect diabetic retinopathy as well as an expert 
ophthalmologist. For the first time in history, software (IDx-DR) has 
been approved by the Food and Drug Administration (FDA) to make 
this diagnosis automatically without the image being seen by an 
ophthalmologist. 
Even if these results are spectacular, they remain for the moment 
confined to specific, relatively narrow tasks, on which there are huge 
databases previously labelled by experts. However, these databases are 
not numerous, and their acquisition and especially their labelling by 
experts is very expensive. It is necessary to ensure that rare cases 
(which by definition are not numerous!) are well represented, that 
there is no bias (gender, age, ethnicity, etc.) and that there are enough 
healthy subjects (which poses an ethical problem when the imaging 
modality is irradiation, for example). Collecting such databases and 
making them available to learning algorithms also raises serious 
confidentiality issues. 
Moreover, artificial intelligence is not limited to the development of 
deep convolutional networks, whose millions of parameters are 
difficult to interpret, and whose adjustment requires training on huge 
databases. There are a variety of classification algorithms that can be 
trained on databases of very variable sizes with very good results3. it 
is also possible to build numerical models of the patient that exploit all 
the knowledge we have in anatomy and physiology to limit ourselves 
to a reduced number of more easily interpretable biophysical 
parameters. Finally, the framework 
 
3. Thirion B. Introduction to Big Data Approaches to Medical Imaging", Collège de France, May 












of the digital patient makes it possible to synthesize medical images 
that are realistic enough to train automatic learning systems, and then 
to transfer the learning to real images. Modern data-science methods 
also make it possible to take into account increasingly "holistic" data 
on the patient, including imaging data (structural and functional), but 
also biological data (genetic, metabolic, etc.) and even behavioral and 
environmental data (lifestyle, etc.). Thus, the UK-Biobank database 
plans to make all this data acquired on more than 100,000 participants 
available to the scientific community 4. In France, a major project to 
collect image data associated with other biomedical data acquired on 
a very large number of patients is being implemented 
in place at the AP-HP to serve the scientific community5. 
The field of application of artificial intelligence in medical imaging 
is intended to serve all medical disciplines. Without being exhaustive, 
we can already mention radiology, dermatology, ophthalmology, 
neurology, psychiatry, cardiology, senology, hepatology, endoscopy, 
endomicroscopy, anatomopathology, radiotherapy and image-guided 
surgery6. New legal issues are being raised 
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by the emergence of these new decision-support softwares7, and 
questions are raised about the very future of certain medical 
specialties8. All these applications and issues are also addressed in 
many other chapters of this book. 
To conclude, I would like to stress that artificial intelligence and 
digital patient are a set of computer tools at the service of a "4 p" 
medicine: more personalized, precise, predictive and preventive in 
order to better treat the real patient. These new tools are intended to 
help doctors, not to replace them. Indeed, some of the physician's 
qualities such as compassion, comprehension, critical thinking and 
professional consciousness (the "4 c")  are still and for a long time the 
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